Fairness to Kids with Cancer Act of 2025
- Sponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Nov 17, 2025
Bottom line
The bill aims to proportionally increase federal funding for pediatric cancer research by linking its share to the demographic representation of children in the U.S. population.
What it actually does
This bill mandates that a specific percentage of all federal cancer research funds be allocated to pediatric cancer research. This percentage is determined annually by the ratio of individuals under 18 to the total U.S. population, as reported by the Bureau of the Census. The requirement begins in fiscal year 2026, aiming to ensure that research funding for children's cancer is proportional to their demographic representation.
Proponents argue
Supporters argue this bill ensures a fair and equitable allocation of federal cancer research dollars, reflecting the proportion of children in the population who are also susceptible to cancer. They contend that pediatric cancers are distinct from adult cancers and often underfunded, making dedicated research crucial for developing treatments tailored to children and improving survival rates and quality of life for young patients.
Opponents contend
Critics might argue that a fixed demographic-based allocation could reduce flexibility in research funding, potentially diverting resources from other critical cancer research areas that may have higher overall incidence or mortality rates, or greater potential for breakthroughs. They might also contend that research priorities should be determined by scientific need and potential impact, rather than a strict population-based formula.
The bill is exceptionally short and clear, allowing for a quick and easy understanding of its provisions.
Section 2
Mandatory Percentage of Federal Cancer Research Funds for Pediatric Cancer Research
This section establishes a new requirement for federal cancer research funding. Starting in fiscal year 2026, the total amount of federal funds dedicated to cancer research must allocate a specific percentage to pediatric cancer research. This percentage is calculated based on the proportion of individuals under 18 years old in the U.S. population relative to the total U.S. population, as determined by the Bureau of the Census in the preceding fiscal year. This aims to ensure that funding for children's cancer research is directly tied to their representation in the overall population.
Supporters argue
Supporters argue that pediatric cancer research is often underfunded relative to the burden of disease and the unique biological characteristics of childhood cancers. This provision ensures that a fair share of federal research dollars is dedicated to finding cures and better treatments for children, acknowledging their distinct needs and the long-term impact of childhood cancer on survivors.
Critics contend
Critics might contend that mandating a fixed percentage based on demographics could hinder the scientific community's ability to respond to emerging research opportunities or to allocate funds based on the prevalence, mortality, or scientific tractability of different cancer types. They might argue that such a formula could lead to suboptimal resource allocation if the most promising research avenues are not in pediatric oncology.
Tradeoffs
The bill creates a tension between ensuring dedicated funding for a vulnerable population (children with cancer) and maintaining flexibility for scientific agencies to allocate research funds based on evolving scientific priorities, disease burden, and the potential for breakthroughs across all cancer types. It also raises questions about whether a demographic ratio is the most appropriate metric for research funding allocation.